DUBLIN--(BUSINESS WIRE)--The "Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.
The global dry eye syndrome market was worth US$ 3.5 Billion in 2018. Looking forward, the market value is projected to reach US$ 5.1 Billion by 2024, exhibiting a CAGR of 6.5% during 2019-2024.
There are several factors that can cause dry eye syndrome such as excessive computer use, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.
Various diseases, such as diabetes, thyroid disorders, Sjogren's syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people.
As per statistics, around 425-430 Million individuals across the globe get affected by diabetes. It causes constant changes in the composition of patient's blood which adversely affects the tear glands resulting in a rising prevalence of dry eye.
Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population.
With the prevalence of dry eyes being fairly high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc.
Key Questions Answered
- How has the global dry eye syndrome market performed so far and how will it perform in the coming years?
- What is the breakup of the global dry eye syndrome market on the basis of region?
- What is the breakup of the global dry eye syndrome market on the basis of disease type?
- What is the breakup of the global dry eye syndrome market on the basis of drug type?
- What is the breakup of the global dry eye syndrome market on the basis of product type?
- What is the breakup of the global dry eye syndrome market on the basis of distribution channel?
- What are the various stages in the value chain of the global dry eye syndrome market?
- What are the key driving factors and challenges in the global dry eye syndrome market?
- What is the structure of the global dry eye syndrome market and who are the key players?
- What is the degree of competition in the global dry eye syndrome market?
Topics Covered
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Properties
4.3 Key Industry Trends
5 Global Dry Eye Syndrome Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Disease Type
5.4 Market Breakup by Drug Type
5.5 Market Breakup by Product
5.6 Market Breakup by Distribution Channels
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Disease Type
6.1 Evaporative Dry Eye Syndrome
6.2 Aqueous Dry Eye Syndrome
7 Market Breakup by Drug Type
7.1 Lubricant Eye Drops
7.2 Anti-inflammatory Drugs
7.3 Autologous Serum Eye Drops
8 Market Breakup by Product
8.1 Liquid Drops
8.2 Gel
8.3 Liquid Wipes
8.4 Eye Ointment
8.5 Others
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.2 Hospital Pharmacies
9.3 Online Pharmacies
10 Market Breakup by Region
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 Middle East and Africa
10.5 Latin America
11 Global Dry Eye Syndrome Industry: SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Global Dry Eye Syndrome Industry: Value Chain Analysis
13 Global Dry Eye Syndrome Industry: Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Global Dry Eye Syndrome Industry: Price Analysis
14.1 Price Indicators
14.2 Price Structure
14.3 Margin Analysis
15 Manufacturing Process
15.1 Product Overview
15.2 Raw Material Requirements
15.3 Manufacturing Process
15.4 Key Success and Risk Factors
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Novartis AG
16.3.2 Allergan PLC
16.3.3 Otsuka Holdings Co. Ltd.
16.3.4 Santen Pharmaceutical Co. Ltd.
16.3.5 Nicox S.A.
16.3.6 Auven Therapeutics
16.3.7 Akorn Inc.
16.3.8 Bausch + Lomb
16.3.9 Alimera Science
16.3.10 GlaxoSmithKline PLC
For more information about this report visit https://www.researchandmarkets.com/research/534f27/opportunity?w=4
